In December 2019, the ISPE Italy Affiliate devoted its annual “ISPE Italy Christmas Night” to Women in Pharma® and unveiled a new award at the event – the Women in Pharma® Graziella Molinari Award – which is named for the Affiliate’s beloved former Vice President, Graziella Molinari. The award celebrates the commitment, perseverance, and competence of women working in life sciences, and is dedicated to enhancing innovation and excellence while encouraging women’s professionalism in the sector. Notably, the award seeks to create strong and credible role models for young women beginning their careers in pharmaceutical and biopharmaceutical manufacturing.
A strong contributor to the ISPE Affiliate, Graziella was a member of the Italy Affiliate Board and a Vice President of the Affiliate, as well as an active member of ISPE. The Women in Pharma® Graziella Molinari Award will be given each year to a young woman who demonstrates distinctive professional achievements in our industry, as Graziella did. The recipient will receive an industry-specific professional course or training program of their choice, donated by the ISPE Italy Affiliate, reflecting its generosity towards others in the spirit of ISPE. The inaugural award, given at last December’s event, was presented by Graziella’s daughter. Sadly, Graziella passed away in 2018 but her influence and dedication to the industry will live on through the award named for her.
In the pharmaceutical industry, which is highly regulated, aseptic processing is a critical component that ensures the sterility of products. Regulators have a set of comprehensive requirements that minimize the risk of contamination. Regulators set the requirements; however, the industry has an obligation to the patients who rely on and expect a drug that is safe and free of contamination....
Like any investment in digital manufacturing systems, demonstrating business payback before and after investment is critical to getting MES projects approved and verifying profitability after investment. Whether it is introducing MES, expanding it to additional sites, switching software, upgrading existing software, or developing electronic production records (EPR) for new drug products,...
Sustainability is emerging as a pivotal force influencing the pharmaceutical industry’s dynamics and steering companies towards transformative change. The focus of this analysis is to delve into the sustainability key performance indicators (KPIs) of prominent pharmaceutical players, namely Pfizer, Sanofi, Glaxo Smith Kline (GSK), Becton Dickinson, Johnson & Johnson, Abbott, Eli Lilly, and...